Serotonin Electrochemical Detection
- Serotonin electrochemical detection is a technique that measures the oxidation of 5-HT at functionalized electrodes with sub-nanomolar sensitivity and high temporal resolution.
- Advanced methods such as FSCV, DPV, and OECT-based aptamer sensors offer precise, selective, and multiplexed readouts for neurotransmitters like serotonin and dopamine.
- Integration of these platforms in biological systems demonstrates high recovery and stability, supporting both in vivo and ex vivo neurophysiological studies.
Serotonin electrochemical detection refers to the direct electronic measurement of serotonin (5-hydroxytryptamine, 5-HT) based on its redox activity at functionalized electrodes. Precise, temporally resolved monitoring of 5-HT is critical for elucidating its role in neurophysiology, disease, and neuromodulation across both in vivo and ex vivo contexts. Electrochemical platforms offer real-time readout of serotonin flux with sub-second resolution, high selectivity, and the ability to multiplex with other neurotransmitters such as dopamine. Recent research demonstrates advances in electrode materials, detection methodologies, and integration of molecular recognition elements, achieving sub-nanomolar sensitivity and enabling complex, drift-tolerant interfacing with biological systems.
1. Mechanisms of Serotonin Electrochemistry
Serotonin is electroactive and undergoes a two-electron, two-proton irreversible oxidation to serotonin quinoneimine upon sufficient anodic polarization. The primary reaction is: This anodic process, typically occurring around 0.36–0.39 V versus Ag/AgCl depending on electrode material and functionalization, forms the basis for electrochemical detection (Santhan et al., 6 Nov 2025).
Electrode surface chemistry critically modulates electron-transfer kinetics (), redox peak potentials, and catalytic current densities. Key properties influencing 5-HT detection include abundance of surface functional groups (carboxyl, hydroxyl, carbonyl), surface charge, defect density (as indicated by in Raman), and the electronic structure of the electrode material.
2. Electrode Material Architectures
Current approaches leverage advanced composite, carbon, or transistor-based sensor formats to maximize sensitivity and selectivity:
- Glassy Carbon Microelectrode Arrays (GC-MEAs): Produced via carbon MEMS (C-MEMS) pyrolysis of SU-8 patterned on Si wafers at 1000 °C, transferred and integrated with platinum interconnects and polymer encapsulation. Raman analysis confirms a high density of edge defects ( ≈ 1.1), and XPS reveals –COOH, C=O, and –OH groups, conferring strong adsorption traits for cationic neurotransmitters (Castagnola et al., 2020).
- Cu₂S/Hβcd-rGO Composite Electrodes: Fabricated as hybrids of copper sulfide nanocrystals, hydroxypropyl-β-cyclodextrin-functionalized reduced graphene oxide (HBcd-rGO), and drop-cast onto glassy carbon electrodes. These feature synergistic charge transfer, high surface area, and cyclodextrin host–guest interactions for analyte pre-concentration (Santhan et al., 6 Nov 2025).
- OECT-Based Aptamer Sensors: Employing organic electrochemical transistors (OECTs) gated via porous hydrogels carrying immobilized 5-HT-specific aptamers. Serotonin-aptamer binding induces electronic modulation of the gate and transconduction of the drain current, enabling highly specific molecular signal conversion (Ni et al., 12 Apr 2026).
Table 1: Summary of Electrode Materials and Key Traits
| Electrode Type | Surface Traits | Notable Properties |
|---|---|---|
| GC-MEA (C-MEMS) | -COOH, C=O, –OH, high edge defects | ≈ cm/s, batch-fabricatable, minimal fouling |
| Cu₂S/Hβcd-rGO/GCE | Cu₂S nanocrystals, rGO, β-cyclodextrin | 61 Ω, LOD 1.2 nM, host–guest capture |
| OECT aptamer-hydrogel | DNA aptamer, hydrogel interface | Aptamer nM, control-referenced |
3. Detection Methodologies and Signal Resolution
Fast Scan Cyclic Voltammetry (FSCV; GC-MEA context)
Employing triangular FSCV waveforms with optimized holding/switching potentials and scan rates (–700 V/s), GC-MEAs resolve voltage peaks corresponding to serotonin and dopamine. With a holding potential of –0.4 V and upper limit +1.0 V, serotonin yields two resolvable oxidation waves:
- Peak I (carbocation): V
- Peak II (quinone-imine): 0 V
In 1:1 DA+:5-HT mixtures, three distinct features indicate effective resolution. The method achieves robust calibration (1 nA/nM × [5-HT], 2) and a limit of detection (LOD) of 310 nM (Castagnola et al., 2020).
DPV and CV (Composite Electrodes)
On Cu₂S/Hβcd-rGO-modified GCE, both cyclic voltammetry and differential pulse voltammetry (DPV) show enhanced anodic response for serotonin (4 μA at 5 V for 50 μM 5-HT). Calibration yields a dual linear range (0.019–0.299 μM, 4.28–403.14 μM), a LOD of 1.2 nM, and high sensitivity (6 μA·μM⁻¹·cm⁻²). Scan rate studies demonstrate an adsorption-controlled process, and EIS indicates a drastic reduction of 7 to 61 Ω, signifying efficient facilitation of charge transfer (Santhan et al., 6 Nov 2025).
OECT-Based Molecular Sensing
Aptamer-functionalized OECTs transduce the conformational change upon 5-HT binding (8 M⁻¹s⁻¹, 9 nM) into gate voltage shifts (0), which drive measurable changes in the drain current. This architecture supports drift rejection by referencing against a hydrogel-matched control pixel, optimizing the symbol error rate (SER) in molecular communication applications (Ni et al., 12 Apr 2026).
4. Analytical Performance and Selectivity
Table 2: Analytical Metrics for Recent Sensor Platforms
| Sensor | Linearity (μM) | LOD | Sensitivity | Selectivity Performance |
|---|---|---|---|---|
| GC-MEA/FSCV | 0.01–0.2 | 10 nM | 0.45 nA/nM | Dopamine, serotonin peak separation |
| Cu₂S/Hβcd-rGO/GCE | 0.019–0.299 & 4.28–403.14 | 1.2 nM | 15.9 μA·μM⁻¹·cm⁻² | No interference from DA, epinephrine, etc. |
| OECT-Aptamer Hybrid | scenario-based | 1.19×10⁴ molecules/symbol | scenario-based | Dopamine/serotonin-pixel separation; drift-corrected |
Cu₂S/Hβcd-rGO/GCE shows nearly complete selectivity for 5-HT against aminophenol, dopamine, epinephrine, hydroquinone, melatonin, and common anions, with a serotonin peak remaining well resolved (<5% current change in interference) (Santhan et al., 6 Nov 2025). GC-MEAs achieve distinct voltage discrimination between 5-HT and dopamine redox transitions, enabling multiplexed neuromodulator measurements (Castagnola et al., 2020). OECT hybrid platforms augment this specificity by configuring DNA aptamers and leveraging control-pixel correction of low-frequency drift (Ni et al., 12 Apr 2026).
5. Integration with Biological Systems and Practical Considerations
Recent systems validate detection in complex biological media:
- GC-MEA in vivo application: Acute rat implants in the caudate-putamen detect DA and 5-HT release following electrical stimulation, with sub-10 nM sensitivity and sub-second kinetic resolution. In vivo assignment of voltammetric peaks requires pharmacological manipulation and careful background subtraction; peak positions can shift by ±50 mV in tissue (Castagnola et al., 2020).
- Cu₂S/Hβcd-rGO/GCE: Demonstrates high recovery and precision (98.7–99.8% recovery in human serum spiked with 5-HT), stability (peak current >95% retained after 15 days at 4 °C), and repeatability (CV 1 RSD <3%, 2) (Santhan et al., 6 Nov 2025).
- OECT-Aptamer Receivers: Designed for neuromodulator readout at brain organoid interfaces, supporting hybrid molecular modulation/demodulation schemes with sub-2% SER and LOD 3 molecules/symbol at 4m source-receiver spacing. The regime for effective control-pixel referencing is explicitly derived: benefit is maximized when pre-subtraction correlation 5 of low-frequency noise exceeds 6 as 7; at short ranges, subtraction is neutral or slightly detrimental (Ni et al., 12 Apr 2026).
6. Fundamental Limitations and Design Challenges
Major constraints in serotonin electrochemical detection include:
- Peak broadening and overlap: At scan rates exceeding 1,000 V/s, dopamine peaks in FSCV broaden, reducing peak voltage separation and complicating multiplexed analysis (Castagnola et al., 2020).
- In vivo specificity: Peak assignments can shift due to tissue heterogeneity and local impedance effects; in vivo serotonin elevation sometimes requires pharmacological intervention (Castagnola et al., 2020).
- Noise and drift in transistor sensors: Low-frequency (flicker, drift) noise can dominate in OECT systems, but matched-control referencing is only beneficial when common-mode correlation is high and thermal noise is minor relative to drift (Ni et al., 12 Apr 2026).
- Sensor fouling: While GC-MEA and Cu₂S/Hβcd-rGO show minimal degradation over multi-hour to multi-day operation, continuous exposure in biological matrices can introduce unpredictable fouling depending on the environment (Castagnola et al., 2020); (Santhan et al., 6 Nov 2025).
7. Future Directions and Emerging Strategies
Progress in serotonin electrochemical detection is anticipated to involve:
- Novel functionalization: Further refinement of electrode composition to tailor selectivity (e.g., aptamers, enzyme interfaces, molecular imprinted polymers).
- Multiplexed/arrayed architectures: Expanded multi-site monitoring arrays, as exemplified by batch-fabricatable GC-MEAs, for spatially resolved brain mapping (Castagnola et al., 2020).
- Integrated control referencing: Enhanced noise rejection in organic transistor-based biosystems for robust operation over extended periods and under variable biological drift (Ni et al., 12 Apr 2026).
- Clinical and translational validation: Broader deployment in real biological samples and disease diagnostics, as demonstrated in serum recovery experiments (Santhan et al., 6 Nov 2025).
The convergence of rapid electron-transfer materials, molecular recognition, and integration with advanced circuit architectures is enabling highly sensitive, selective, and drift-tolerant serotonin electrochemical sensing across diverse biological and communication scenarios.